PepStack
Research-backed peptide information you can trust.
Safety data, evidence ratings, and plain-English explanations for 89 peptides. Every claim cited. Every risk disclosed. Updated regularly.
Featured Peptides
Abaloparatide (Tymlos)
FDA ApprovedFDA-approved synthetic PTHrP(1-34) analog that stimulates new bone formation and reduces vertebral (86% RRR) and nonvertebral (43% RRR) fracture risk in postmenopausal women with osteoporosis (PMID 27533157, NCT01343004).
Calcitonin Salmon (Miacalcin, Fortical)
FDA ApprovedFDA-approved synthetic 32-amino-acid polypeptide identical to salmon calcitonin, used for postmenopausal osteoporosis, Paget's disease, and hypercalcemia. Intranasal 200 IU reduced new vertebral fractures by 33% versus placebo in the PROOF trial (N=1255; PMID 10996576). Well-documented analgesic properties for vertebral compression fracture pain. Considered second-line due to modest efficacy versus newer agents and a cancer risk signal with long-term use (FDA Label).
Cetrorelix (Cetrotide)
FDA ApprovedFDA-approved synthetic decapeptide GnRH antagonist used to inhibit premature LH surges during controlled ovarian stimulation for IVF, with 0.25 mg daily established as the minimal effective multidose regimen (FDA label ANDA218150; PMID 9130900).
Dasiglucagon (Zegalogue)
FDA ApprovedFDA-approved (March 2021) glucagon receptor agonist analog for the treatment of severe hypoglycemia in pediatric (age 6+) and adult patients with diabetes, marketed as Zegalogue (PMID 34047955; NDA 214231).
How We're Different
Safety First
Every peptide page leads with safety data and known risks.
Evidence-Rated
Clear ratings so you know what’s proven and what’s promising.
Fully Cited
Every claim links to its source. No bro-science.
Transparent
We tell you what we don’t know, not just what we do.
Coming soon: personalized peptide insights
Upload your bloodwork, define your goals, and see research-backed correlations matched to your biology.
No spam. We'll notify you when the app launches.